A virtual CPD meeting you can join from the comfort of your home / office. Please register for CPD.


  • Multiple Myeloma: Management of Myeloma in the COVID era: What are the treatment options in 2020? 
  • Genomic testing in haematological malignancies: why, when and how.
  • ITP:  New developments in the management of Immune Thrombocytopenic Purpura. 
  • CML Update: New ELN & BCSH guidelines. Management of sub-optimal responses in CML and sequencing of TKI’s.


  • Haematology consultants
  • Trainees
  • Clinical nurse specialists
  • Pharmacists


  • Dr Karthik Ramasamy, Consultant Haematologist & Lead for Myeloma and Plasma Cell Disorders Clinician, Oxford University Hospital.
  • Dr Anna Godfrey, Consultant Haematologist, Cambridge University Hospitals NHS FT, Haemato-oncology, Clinical Lead for the East Midlands and East of England Genomics Laboratory Hub.
  • Dr Drew Provan, Consultant Haematologist and Emeritus Reader in Autoimmune Haematology, Department of Haematology, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London.
  • Dr Jenny Byrne, Associate Professor in Haematology, Honorary Consultant and Transplant Director, Nottingham City Hospital and University of Nottingham.

For more information, please contact Humayun Ahmad: h.ahmad@nhs.net

Once registered participants will be provided an online link to join the proceedings of the meeting.

Limited places, first come first served basis.

  • 08:30 - 12/09/2020 to 14:00 - 12/09/2020
  • Virtual meeting via Zoom platform, United Kingdom